{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:59:01Z","timestamp":1760295541757},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2009,6,1]]},"DOI":"10.2174\/138945009788488468","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T00:58:41Z","timestamp":1243990721000},"page":"530-536","source":"Crossref","is-referenced-by-count":6,"title":["Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR\/ABL"],"prefix":"10.2174","volume":"10","author":[{"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/69416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:25:45Z","timestamp":1448267145000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-4501&volume=10&issue=6&spage=530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138945009788488468","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}